BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ZContent.net//ZapCalLib 1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
SUMMARY:New Strategies for Photocatalytic Bond Activation
LOCATION:Chemistry A101
TZID:America/Denver
DTSTART:20194201T000000
UID:2026-04-28-23-15-55@natsci.colostate.edu
DTSTAMP:20260428T231555
Description:About the Seminar\n\nAlcohols are one of the most prevalent cla
 sses of organic molecules in natural products\, while C–H bonds are ubiq
 uitous in diverse compounds from complex medicines to simple hydrocarbons.
  We are investigating the use of cobalt complexes as light-driven catalyst
 s for the activation of alcohols without prefunctionalization. Application
 s to deoxygenation as well as C–C bond-forming processes are being pursu
 ed. In parallel\, we are developing a photoredox C–H bond activation met
 hod for the direct functionalization of caged hydrocarbons such as adamant
 ane and higher order diamondoids. We have developed a new H-atom transfer 
 catalyst with an unprecedented selectivity profile between different C–H
  bonds.\n\nAbout the Speaker\n\nDave Martin grew up in Calgary\, Alberta\,
  Canada and received his Bachelor of Science degree in Chemistry from the 
 University of British Columbia. In 2005\, he moved to Montreal to work at 
 the Merck-Frosst Centre for Therapeutic Research in the Medicinal Chemistr
 y Department. In 2011\, Dave obtained his Ph.D. from the University of Cal
 ifornia\, Irvine where he worked with Prof. Chris Vanderwal on the applica
 tion of Zincke aldehydes toward the synthesis of Strychnos alkaloids\, inc
 luding a short synthesis of strychnine. After pursuing post-doctoral resea
 rch in the lab of Prof. Dave MacMillan in the area photoredox catalysis\, 
 Dave joined the Chemistry Department at the University of California\, Riv
 erside. His group develops new catalytic transformations and novel strateg
 ies for bond activation. The overarching goal of his research program is t
 o enable the efficient synthesis of biologically active targets and synthe
 tic probes for the study and treatment of human disease. 4:00 pm
END:VEVENT
END:VCALENDAR
